NRX Pharmaceuticals Inc - Continues to Finalize a New Drug Approval Application for Intravenous Ketamine (NRX-100), to Be Submitted This Year
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.